key: cord-1022731-3c0njj5i
authors: Zhou, Ruihai
title: Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?
date: 2020-05-03
journal: Eur Heart J
DOI: 10.1093/eurheartj/ehaa392
sha: a06a44cd792be67a2970d3454642e4c772e1e467
doc_id: 1022731
cord_uid: 3c0njj5i

nan

Since the first cases reported in Wuhan, China, coronavirus disease 2019 (COVID-19) has spread swiftly around the world, and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The development of myocardial injury is associated with significantly worse clinical course and increased mortality. However, currently it is unclear whether cardiac injury observed in COVID-19 patients results directly from viral infection of the myocardium, i.e. SARS-CoV-2 viral myocarditis, or indirectly from the complications of COVID-19.

Several cases of acute myocarditis or, more appropriately, myocardial inflammation, associated with COVID-19 have been reported. 1, 2 However, there are scant myocardial pathological data from COVID-19 patients. The only post-mortem pathological study in a COVID-19 patient thus far was on a 50-year-old male with COVID-19 who died from cardiac arrest, in China; the results showed significant lung damage, but no substantial damage in the myocardium was found except for a few interstitial mononuclear inflammatory infiltrates. 3 In this issue, Sala et al. report the first direct evidence of myocardial inflammation by endomyocardial biopsy (EMB) in a COVID-19 patient. 2 EMB revealed diffuse T-lymphocytic inflammatory infiltrates with significant interstitial oedema and limited focal necrosis. However, no SARS-CoV-2 genome was detected within the myocardium. 2 On cardiac magnetic resonance (CMR), the patient had evidence of myocardial oedema and left ventricular systolic dysfunction with basal-mid left ventricular hypokinesis and preserved apical motion, a pattern indicative of reverse Takotsubo cardiomyopathy. 2 Takotsubo cardiomyopathy is known to have regional myocardial oedema on CMR, 4 and injury to myocytes and infiltration of lymphocytes and macrophages in the autopsied specimens. 5 Given the lack of evident myocardial SARS-CoV-2 viral genome and shared CMR feathers with Takotsubo cardiomyopathy, the cardiac manifestation in this reported COVID-19 patient could be that of reverse Takotsubo cardiomyopathy in the setting of COVID-19 stress. 4 Nevertheless, EBM is limited by sampling error and usually only a portion of patients infected with a virus causing myocarditis develop viral myocarditis; therefore, it is possible that with more autopsy evidence of SARS-CoV-2, viral myocarditis will emerge.

Conflict of interest: none declared.

Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)

Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Cardiac magnetic resonance in Takotsubo syndrome

Inflammation in takotsubo cardiomyopathy? Inquiry from 'Guidelines for Diagnosis and Treatment of Myocarditis